Bhattacharjee S, Sullivan MJ, Wynn RR, Demagall A, et al. PARP inhibitors chemopotentiate and synergize with cisplatin to inhibit bladder cancer cell survival and tumor growth. BMC Cancer 2022;22:312.
PMID: 35321693